InterCure Ltd. , together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally.
Intercure stock last closed at $1.47, down 2.65% from the previous day, and has decreased 15.03% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.06 percentage points. Intercure stock is currently +25.64% from its 52-week low of $1.17, and -18.33% from its 52-week high of $1.80.
As of Oct 27, 2025, there are 47.16M INCR shares outstanding. The market value of INCR is $69.33M. In the past 24 hours, 7300 INCR shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy INCR stock.
We believe that eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal details so you can buy INCR stock today.
Now that you have filled out your info on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Watch the tutorial below for more details depositing money into your new investment account.
Once you have identified the best place to buy Intercure stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on INCR's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge INCR's fair value.
Using relative valuations methods:
You can do more valuation research on INCR's stock here.
You can dig deeper into what analysts are saying on the Intercure stock forecast page.
Last year, INCR revenue was $74.81M. During the last four year, INCR's revenue has grown by 16.28% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 10.36%.
You can analyze INCR's earnings and revenue performance here.
Over the last year, insiders at INCR have not bought or sold any shares.
Dig into more about who owns INCR stock here.
No, Intercure doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary order types:
Hit the Open Trade button and eToro will place the order.
If you want additional info about investing in stocks on eToro, watch the how to video below:
Now that you own some shares in INCR, you'll want to keep up with your new stock purchase.
Start a watchlist to see the latest developments about your INCR stock.
To summarize, here are the 6 steps to buy Intercure stock:
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to watch your new investment in Intercure, click below.